Karsell PR, McDougall JC (1993) Diagnostic tests for lung cancer. Mayo Clin Proc 68:288–296Karsell PR, McDougall JC. Diagnostic tests for lung cancer. Mayo Clin Proc 1993; 68:288 -296.Karsell PR, McDougall JC. Diagnostic tests for lung cancer. Mayo Clin Proc 1993; 68: 288-96....
Diagnostic tests for lung cancer 来自 NCBI 喜欢 0 阅读量: 32 作者: KARSELL, PHILIP R,McDOUGALL, JOHN C 摘要: The goals of diagnostic testing in patients with suspected lung cancer are to establish the diagnosis and to determine the stage of the disease so that appropriate therapy can be ...
Testing solutionsSpanning the Lung Cancer Continuum of Care Access fast, reliable, and actionable biological insights with our genomic and proteomic tests to gain a deeper understanding of each patient’s disease state, help expedite diagnosis, and guide confident treatment decisions. ...
Testing solutionsSpanning the Lung Cancer Continuum of Care Access fast, reliable, and actionable biological insights with our genomic and proteomic tests to gain a deeper understanding of each patient’s disease state, help expedite diagnosis, and guide confident treatment decisions. ...
Methylation biomarkers can be detected not only from tissue but also in serum, fecal, and plasma16, indicating its potential as a noninvasive method for cancer detection. It has been reported that in vitro diagnostic tests using DNA methylation-based biomarkers have been approved by the U.S. ...
Introduction: Lung cancer is the second mortality cause in Mexico, therefore, the main objective of this study was to determine the degree of diagnostic certainty of histology and cytology studies used at the National Institute of Respiratory Disease, where a sample quality control method is also ...
for small local tumors (stage I) is 70–90%. By contrast, about 75% of patients have progressed to stage III/IV or distant metastatic disease (stage IV) at the time of diagnosis. Although there have been significant advances in the treatment of advanced lung cancer, the 1-year survival ...
The pathological distinction between malignant pleural mesothelioma (MPM)and adenocarcinoma (ADCA) of the lung can be cumbersome using established methods... GJ Gordon,RV Jensen,LL Hsiao,... - 《Cancer Research》 被引量: 2516发表: 2002年 Guidelines for Meta-analyses Evaluating Diagnostic Tests To ...
Benefits and harms of CT screening for lung cancer: a systematic review. JAMA. 2012;307(22):2418-2429. doi:10.1001/jama.2012.5521ArticlePubMedGoogle ScholarCrossref 9. American Lung Association Lung Cancer Screening Committee. Providing Guidance on Lung Cancer Screening to Patients and Physicians...
Disclosed is a diagnostic marker for lung cancer comprising HpαR as an active ingredient. Because blood, which is relatively easy to sample, is employed as a specimen, the diagnosti